Company Filing History:
1 out of 1,209 
1 out of 443 
Years Active: 2024
Title: Craig Strathdee: Innovator in Cancer Treatment
Introduction
Craig Strathdee is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on the treatment of peroxisome proliferator-activated receptor gamma (PPARG) activated cancer, particularly bladder cancer.
Latest Patents
Strathdee holds one patent titled "Compositions and methods for treatment of peroxisome proliferator-activated receptor gamma (PPARG) activated cancer." This patent provides compositions and methods for treating PPARG activated cancer, including the use of PPARG signaling modulators and inverse-agonists for therapeutic and prophylactic purposes.
Career Highlights
Throughout his career, Craig Strathdee has worked with prestigious institutions such as Dana-Farber Cancer Institute Inc. and The Broad Institute, Inc. His work at these organizations has allowed him to advance his research and contribute to the understanding of cancer treatment.
Collaborations
Strathdee has collaborated with notable colleagues, including Jonathan Goldstein and Matthew Meyerson, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Craig Strathdee's innovative contributions to cancer treatment exemplify the importance of research and collaboration in the medical field. His work continues to pave the way for advancements in therapeutic options for patients.